Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mannkind Corp (MNKD)

Mannkind Corp (MNKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mannkind Corp 1 CASPER STREET DANBURY CT 06810 USA

www.mannkindcorp.com P: 818-661-5000

Description:

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.

Key Statistics

Overview:

Market Capitalization, $K 1,386,089
Enterprise Value, $K 1,273,589
Shares Outstanding, K 272,316
Annual Sales, $ 198,960 K
Annual Net Income, $ -11,940 K
Last Quarter Sales, $ 66,260 K
Last Quarter Net Income, $ 10,630 K
EBIT, $ 31,400 K
EBITDA, $ 39,320 K
60-Month Beta 1.32
% of Insider Shareholders 3.00%
% of Institutional Shareholders 49.55%
Float, K 264,147
% Float 97.00%
Short Volume Ratio 0.37

Growth:

1-Year Return 23.59%
3-Year Return 4.14%
5-Year Return 361.47%
5-Year Revenue Growth 614.14%
5-Year Earnings Growth 93.22%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.05 on 05/08/24
Next Earnings Date 08/05/24
Earnings Per Share ttm 0.03
EPS Growth vs. Prev Qtr 300.00%
EPS Growth vs. Prev Year 200.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 03/03/17

MNKD Ratios

Ratio
Price/Earnings ttm 174.00
Price/Earnings forward 50.52
Price/Earnings to Growth N/A
Return-on-Equity % -3.35%
Return-on-Assets % 2.08%
Profit Margin % -6.00%
Debt/Equity -0.61
Price/Sales 7.14
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.84
Interest Coverage -0.59
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar